Clinical Trial Update: A Study of Combination of Gemcitabine, Oxaliplatin (GEMOX)-Sorafenib in Patients With Advanced Biliary Tract Cancer [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 study evaluating GEMOX combined with sorafenib in advanced biliary tract cancers was terminated; results posted in 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biliary Tract Cancer
• Cholangiocarcinoma
• Gallbladder Cancer

Drugs mentioned

• Gemcitabine (Gemcitabine)
• OXALIPLATIN (Oxaliplatin)
• Sorafenib (Sorafenib)

Snippet

Sponsor: University of Miami | Conditions: Cholangiocarcinoma, Biliary Tract Cancer | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2015-02-13